PYXS

SEC source: 0000919574-26-006815 · ownership.xml · derivative · entry 1

GordonMD Global Investments LP · CIK 0002039349 · 10% owner

GordonMD Long Biased Master Fund LP · CIK 0002103789 · 10% owner

GordonMD Long Biased GP LLC · CIK 0002103778 · 10% owner

Gordon Craig D · CIK 0002103811 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 7,172,000

Underlying: Common Stock · 7,172,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Exercise price of $3.5, subject to adjustments as set forth in the Common Stock Purchase Warrant.

F2 · price: The combined public offering price for each share of common stock and accompanying Common Stock Purchase Warrant is $2.90.

F4 · derivative.exercise_date: The Common Stock Purchase Warrant will not be exercisable unless and until (i) the issuer's stockholders approve an amendment to the issuer's amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock (the "Charter Amendment") and (ii) the Charter Amendment is filed with, and becomes effective under the laws of, the State of Delaware (the date on which the Charter Amendment becomes effective, the "Charter Amendment Effective Date").

F5 · derivative.expiration_date: The Common Stock Purchase Warrant will expire on the earlier of (i) the fifth anniversary of the Charter Amendment Effective Date and (ii) the 30th calendar day following the later of the Charter Amendment Effective Date and the date on which the issuer publicly discloses the results of the overall survival analysis for its Phase 1 monotherapy study of MICVO in second-line and later recurrent or metastatic head and neck squamous cell carcinoma.

F1 · ownership.nature: The securities to which this filing relates are held directly by GordonMD Long Biased Master Fund LP (the "Master Fund") to which GordonMD Global Investments LP (the "Investment Manager") serves as investment manager. Craig D. Gordon ("Mr. Gordon") is the managing member of GordonMD Long Biased GP LLC (the "GP"), the general partner of the Master Fund. Each of the Master Fund, the GP and Mr. Gordon disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.

SEC source: 0000919574-26-006609 · ownership.xml · derivative · entry 2

GordonMD Global Investments LP · CIK 0002039349 · 10% owner

GordonMD Long Biased Master Fund LP · CIK 0002103789 · 10% owner

GordonMD Long Biased GP LLC · CIK 0002103778 · 10% owner

Gordon Craig D · CIK 0002103811 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 7,546,766

Underlying: Common Stock · 7,546,766 shares

Expires not disclosed

F3 · derivative.exercise_price: Exercise price of $3.5, subject to adjustments as set forth in the Common Stock Purchase Warrant.

F2 · price: The combined public offering price for each share of common stock and accompanying Common Stock Purchase Warrant is $2.90.

F4 · derivative.exercise_date: The Common Stock Purchase Warrant will not be exercisable unless and until (i) the issuer's stockholders approve an amendment to the issuer's amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock (the "Charter Amendment") and (ii) the Charter Amendment is filed with, and becomes effective under the laws of, the State of Delaware (the date on which the Charter Amendment becomes effective, the "Charter Amendment Effective Date").

F5 · derivative.expiration_date: The Common Stock Purchase Warrant will expire on the earlier of (i) the fifth anniversary of the Charter Amendment Effective Date and (ii) the 30th calendar day following the later of the Charter Amendment Effective Date and the date on which the issuer publicly discloses the results of the overall survival analysis for its Phase 1 monotherapy study of MICVO in second-line and later recurrent or metastatic head and neck squamous cell carcinoma.

F1 · ownership.nature: The securities to which this filing relates are held directly by GordonMD Long Biased Master Fund LP (the "Master Fund") to which GordonMD Global Investments LP (the "Investment Manager") serves as investment manager. Craig D. Gordon ("Mr. Gordon") is the managing member of GordonMD Long Biased GP LLC (the "GP"), the general partner of the Master Fund. Each of the Master Fund, the GP and Mr. Gordon disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.

SEC source: 0000919574-26-006609 · ownership.xml · nonDerivative · entry 1

GordonMD Global Investments LP · CIK 0002039349 · 10% owner

GordonMD Long Biased Master Fund LP · CIK 0002103789 · 10% owner

GordonMD Long Biased GP LLC · CIK 0002103778 · 10% owner

Gordon Craig D · CIK 0002103811 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 15,541,909

F2 · price: The combined public offering price for each share of common stock and accompanying Common Stock Purchase Warrant is $2.90.

F1 · ownership.nature: The securities to which this filing relates are held directly by GordonMD Long Biased Master Fund LP (the "Master Fund") to which GordonMD Global Investments LP (the "Investment Manager") serves as investment manager. Craig D. Gordon ("Mr. Gordon") is the managing member of GordonMD Long Biased GP LLC (the "GP"), the general partner of the Master Fund. Each of the Master Fund, the GP and Mr. Gordon disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.

SEC source: 0001193125-26-384391 · ownership.xml · derivative · entry 1

Civik Thomas · CIK 0001723092 · Director · CEO & Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,503,050

Underlying: Common Stock · 2,503,050 shares

Expires 2036-09-04

F1 · derivative.exercise_date: The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of September 4, 2026 and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

SEC source: 0001193125-26-359525 · ownership.xml · derivative · entry 1

Dupont Jakob · CIK 0001553335 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,000

Underlying: Common Stock · 46,000 shares

Expires 2036-08-20

F1 · derivative.exercise_date: The shares subject to this option will vest in equal monthly installments through October 31, 2026, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001193125-26-352206 · ownership.xml · derivative · entry 1

Civik Thomas · CIK 0001723092 · Director · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 941,087

Underlying: Common Stock · 250,956 shares

Expires 2036-02-03

F1 · derivative.exercise_date: Represents the performance-based portion of an option that was granted on February 3, 2026, which shares subject to this portion of the option were to become vested in full upon the completion of a successful financing transaction or a successful strategic transaction during the reporting person's continued service as Interim Chief Executive Officer or within six months thereafter. The performance conditions were deemed to have been met on August 12, 2026, as determined by the Board.

SEC source: 0001193125-26-294708 · ownership.xml · derivative · entry 3

Dupont Jakob · CIK 0001553335 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 357,461

Underlying: Common Stock · 35,000 shares

Expires 2033-09-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Award of stock options to purchase Common Shares with a vesting commencement date of August 23, 2024. These options vest and become exercisable in three equal annual tranches from August 23, 2023, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).

SEC source: 0001193125-26-294708 · ownership.xml · nonDerivative · entry 2

Dupont Jakob · CIK 0001553335 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,741

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on Septemeber 24, 2025.

F2 · price: Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 3 of this Form 4.

F3 · price: The transaction was executed in multiple trades in prices ranging from $3.00 to $3.36.

SEC source: 0001193125-26-294708 · ownership.xml · nonDerivative · entry 1

Dupont Jakob · CIK 0001553335 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-124348 · ownership.xml · derivative · entry 1

FLAVIN JOHN L · CIK 0001126556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,867

Underlying: Common Stock · 45,867 shares

Expires 2036-03-24

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001193125-26-124313 · ownership.xml · derivative · entry 1

Palani Santhosh · CIK 0002013475 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,867

Underlying: Common Stock · 45,867 shares

Expires 2036-03-24

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001193125-26-124333 · ownership.xml · derivative · entry 1

Lewis-Hall Freda C · CIK 0001437909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,867

Underlying: Common Stock · 45,867 shares

Expires 2036-03-24

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001193125-26-124342 · ownership.xml · derivative · entry 1

Metzger Michael A · CIK 0001507220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,867

Underlying: Common Stock · 45,867 shares

Expires 2036-03-24

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001193125-26-124388 · ownership.xml · derivative · entry 1

Dupont Jakob · CIK 0001553335 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,867

Underlying: Common Stock · 45,867 shares

Expires 2036-03-24

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001193125-26-124319 · ownership.xml · derivative · entry 1

HUMPHREY RACHEL · CIK 0001579781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,867

Underlying: Common Stock · 45,867 shares

Expires 2036-03-24

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001193125-26-124325 · ownership.xml · derivative · entry 1

Cline Darren S · CIK 0001633639 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,867

Underlying: Common Stock · 45,867 shares

Expires 2036-03-24

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001193125-26-124380 · ownership.xml · derivative · entry 2

Wadhane Jitendra · CIK 0001941706 · Prin Fin & Acct Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,635

Underlying: Common Stock · 262,635 shares

Expires 2036-03-24

F2 · derivative.exercise_date: The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 24, 2026 and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued emmployment through the applicable vesting date.

SEC source: 0001193125-26-124380 · ownership.xml · nonDerivative · entry 1

Wadhane Jitendra · CIK 0001941706 · Prin Fin & Acct Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 512,882

F1 · shares: Represents restricted stock units that vest 25% on March 31, 2026, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

SEC source: 0001193125-26-039951 · ownership.xml · derivative · entry 1

Civik Thomas · CIK 0001723092 · Director · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 690,131

Underlying: Common Stock · 690,131 shares

Expires 2036-02-03

F1 · derivative.exercise_date: The shares subject to this option will vest in 12 equal monthly installments, commencing on the grant date and subject to the reporting person's continued service as Interim Chief Executive Officer through the applicable vesting date.

SEC source: 0000905148-26-001434 · form4.xml · nonDerivative · entry 3

HUMPHREY RACHEL · CIK 0001579781 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 81,309

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2024.

F2 · price: Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 3 through 4 of this Form 4.

F4 · price: The transaction was executed in multiple trades in prices ranging from $0.97 to $1.09.

SEC source: 0000905148-26-001434 · form4.xml · nonDerivative · entry 2

HUMPHREY RACHEL · CIK 0001579781 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,205

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2024.

SEC source: 0000905148-26-001434 · form4.xml · nonDerivative · entry 1

HUMPHREY RACHEL · CIK 0001579781 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,405

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2024.

F2 · price: Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 3 through 4 of this Form 4.

F3 · price: The transaction was executed in multiple trades in prices ranging from $0.97 to $0.98.

SEC source: 0000950170-25-048892 · ownership.xml · derivative · entry 1

FLAVIN JOHN L · CIK 0001126556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,979

Underlying: Common Stock · 36,979 shares

Expires 2035-03-31

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-25-048895 · ownership.xml · derivative · entry 1

Palani Santhosh · CIK 0002013475 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,979

Underlying: Common Stock · 36,979 shares

Expires 2035-03-31

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-25-048900 · ownership.xml · derivative · entry 1

Lewis-Hall Freda C · CIK 0001437909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,979

Underlying: Common Stock · 36,979 shares

Expires 2035-03-31

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-25-048903 · ownership.xml · derivative · entry 1

Metzger Michael A · CIK 0001507220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,979

Underlying: Common Stock · 36,979 shares

Expires 2035-03-31

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-25-048898 · ownership.xml · derivative · entry 1

Dupont Jakob · CIK 0001553335 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,979

Underlying: Common Stock · 36,979 shares

Expires 2035-03-31

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-25-048901 · ownership.xml · derivative · entry 1

HUMPHREY RACHEL · CIK 0001579781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,979

Underlying: Common Stock · 36,979 shares

Expires 2035-03-31

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-25-048899 · ownership.xml · derivative · entry 1

Cline Darren S · CIK 0001633639 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,979

Underlying: Common Stock · 36,979 shares

Expires 2035-03-31

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-25-048894 · ownership.xml · derivative · entry 1

Civik Thomas · CIK 0001723092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,979

Underlying: Common Stock · 36,979 shares

Expires 2035-03-31

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-25-048905 · ownership.xml · derivative · entry 1

Sullivan Lara · CIK 0001769457 · Director · President ,CEO & CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 918,308

Underlying: Common Stock · 918,308 shares

Expires 2035-03-31

F1 · derivative.exercise_date: The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 31,2025 and the remainder vesting in 36 equal monthly instalments thereafter subject to the reporting person's continued employment through the applicable vesting date.

SEC source: 0000950170-25-048902 · ownership.xml · derivative · entry 1

Wadhane Jitendra · CIK 0001941706 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 263,782

Underlying: Common Stock · 263,782 shares

Expires 2035-03-31

F1 · derivative.exercise_date: The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 31,2025 and the remainder vesting in 36 equal monthly instalments thereafter subject to the reporting person's continued employment through the applicable vesting date.

SEC source: 0000950170-25-048893 · ownership.xml · derivative · entry 1

Connealy Pamela Ann · CIK 0001796310 · CFO & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 414,163

Underlying: Common Stock · 414,163 shares

Expires 2035-03-31

F1 · derivative.exercise_date: The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 31, 2025 and the remainder vesting in 36 equal monthly installments thereafter subject to the reporting person's continued emmployment through the applicable vesting date.

SEC source: 0000950170-24-139616 · ownership.xml · derivative · entry 1

Sullivan Lara · CIK 0001769457 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,135,000

Underlying: Common Stock · 1,135,000 shares

Expires 2034-12-23

F1 · derivative.exercise_date: The shares subject to this option vest in full on December 23, 2025, subject to the Reporting Person's continued employment through the vesting date.

SEC source: 0000950170-24-139608 · ownership.xml · derivative · entry 1

Connealy Pamela Ann · CIK 0001796310 · CFO & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 310,000

Underlying: Common Stock · 310,000 shares

Expires 2034-12-23

F1 · derivative.exercise_date: The shares subject to this option vest in full on December 23, 2025, subject to the Reporting Person's continued employment through the vesting date.

SEC source: 0000950170-24-139598 · ownership.xml · derivative · entry 1

Wadhane Jitendra · CIK 0001941706 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2034-12-23

F1 · derivative.exercise_date: The shares subject to this option vest in full on December 23, 2025, subject to the Reporting Person's continued employment through the vesting date.

SEC source: 0000950170-24-131606 · ownership.xml · nonDerivative · entry 2

Connealy Pamela Ann · CIK 0001796310 · CFO & COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 1,199,143

F2 · price: The price reported in column 4 is a weighted-average price.These shares were purchased in multiple transactions at prices ranging from $1.93 to $1.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

SEC source: 0000950170-24-131606 · ownership.xml · nonDerivative · entry 1

Connealy Pamela Ann · CIK 0001796310 · CFO & COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,115,743

F1 · ownership.nature: These shares are held directly by the Personal Def Ben Pln Trust, a revocable trust for which the Reporting Person and their spouse are the trustees.

SEC source: 0000950170-24-071438 · ownership.xml · derivative · entry 1

Metzger Michael A · CIK 0001507220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,683

Underlying: Common Stock · 70,683 shares

Expires 2034-06-10

F1 · derivative.exercise_date: The shares subject to this option shall vest in three equal annual installments beginning on the first anniversary of June 10, 2024, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-24-070833 · ownership.xml · nonDerivative · entry 1

Palani Santhosh · CIK 0002013475 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

F1 · shares: Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-24-038104 · ownership.xml · nonDerivative · entry 1

FLAVIN JOHN L · CIK 0001126556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 413,015

F1 · shares: Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-24-038103 · ownership.xml · nonDerivative · entry 1

Lewis-Hall Freda C · CIK 0001437909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 241,405

F1 · shares: Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-24-038102 · ownership.xml · nonDerivative · entry 1

Dupont Jakob · CIK 0001553335 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,741

F1 · shares: Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-24-038099 · ownership.xml · nonDerivative · entry 1

HUMPHREY RACHEL · CIK 0001579781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,805

F1 · shares: Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-24-038105 · ownership.xml · nonDerivative · entry 1

Cline Darren S · CIK 0001633639 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 251,405

F1 · shares: Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-24-038098 · ownership.xml · derivative · entry 1

Civik Thomas · CIK 0001723092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,024

Underlying: Common Stock · 44,024 shares

Expires 2034-03-26

F1 · derivative.exercise_date: The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0000950170-24-038108 · ownership.xml · nonDerivative · entry 1

Connealy Pamela Ann · CIK 0001796310 · CFO & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,110,293

F1 · shares: Represents restricted stock units that vest 25% on the first anniversary of March 26, 2024, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

SEC source: 0000950170-24-038106 · ownership.xml · derivative · entry 1

Sullivan Lara · CIK 0001769457 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,071,242

Underlying: Common Stock · 1,071,242 shares

Expires 2034-03-26

F1 · derivative.exercise_date: The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 26, 2024 and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

SEC source: 0000950170-24-038097 · ownership.xml · nonDerivative · entry 1

Wadhane Jitendra · CIK 0001941706 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 398,421

F1 · shares: Represents restricted stock units that vest 25% on the first anniversary of March 26, 2024, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

SEC source: 0000950170-24-030865 · ownership.xml · derivative · entry 1

Palani Santhosh · CIK 0002013475 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,760

Underlying: Common Stock · 69,760 shares

Expires 2034-03-12

F1 · derivative.exercise_date: The shares subject to this option shall vest in three equal annual installments beginning on the first anniversary of March 12, 2024, subject to the reporting person's continued service through the applicable vesting date.